Technical Analysis for TGTX - TG Therapeutics, Inc.

Grade Last Price % Change Price Change
grade D 5.59 4.29% 0.23
TGTX closed up 4.29 percent on Thursday, October 17, 2019, on approximately normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Up
See historical TGTX trend table...

Date Alert Name Type % Chg
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Crossed Above 20 DMA Bullish 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Up 3 Days in a Row Strength 0.00%
Up 4 Days in a Row Strength 0.00%
Up 5 Days in a Row Strength 0.00%
1,2,3 Retracement Bearish Bearish Swing Setup 4.29%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 4.29%
Narrow Range Bar Range Contraction 4.29%
Inside Day Range Contraction 4.29%

Older signals for TGTX ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
TG Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of innovative and medically important pharmaceutical products for the treatment of cancer and other underserved therapeutic needs. The company is developing two advanced therapies targeting hematological malignancies. The TGTX-1101 (ublituximab) is a novel, third generation monoclonal antibody that targets a specific and unique epitope on the CD20 antigen found on mature B-lymphocytes, which is in clinical development for patients with relapsed and refractory non-Hodgkin's lymphoma. The TGR-1202 is an orally available PI3K delta inhibitor believed to be important in the proliferation and survival of B-lymphocytes. TG Therapeutics, Inc. is headquartered in New York, New York.
Biopharmaceutical Cancer Treatment Of Cancer Monoclonal Antibodies Lymphoma Antibody Drug Conjugates Hematological Malignancies Camidanlumab Tesirine Cd20
Is TGTX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 9.38
52 Week Low 3.32
Average Volume 1,025,461
200-Day Moving Average 6.5806
50-Day Moving Average 6.1083
20-Day Moving Average 5.4313
10-Day Moving Average 5.267
Average True Range 0.3111
ADX 29.13
+DI 18.5406
-DI 23.6649
Chandelier Exit (Long, 3 ATRs ) 5.6367
Chandelier Exit (Short, 3 ATRs ) 5.8833
Upper Bollinger Band 5.9995
Lower Bollinger Band 4.8631
Percent B (%b) 0.64
BandWidth 20.923168
MACD Line -0.2485
MACD Signal Line -0.3109
MACD Histogram 0.0624
Fundamentals Value
Market Cap 348.32 Million
Num Shares 62.3 Million
EPS -1.95
Price-to-Earnings (P/E) Ratio -2.87
Price-to-Sales 3189.49
Price-to-Book 6.24
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 6.03
Resistance 3 (R3) 5.99 5.81 5.96
Resistance 2 (R2) 5.81 5.69 5.83 5.93
Resistance 1 (R1) 5.70 5.62 5.75 5.74 5.91
Pivot Point 5.51 5.51 5.54 5.53 5.51
Support 1 (S1) 5.40 5.40 5.46 5.44 5.27
Support 2 (S2) 5.22 5.33 5.24 5.25
Support 3 (S3) 5.11 5.22 5.22
Support 4 (S4) 5.15